Surmodics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
SRDX Nasdaq 3840 www.surmodics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Surmodics, Inc.

QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound? - Jun 6th, 2025 9:31 am
Why Is SurModics (SRDX) Up 6% Since Last Earnings Report? - May 30th, 2025 9:31 am
Are Options Traders Betting on a Big Move in Surmodics Stock? - May 2nd, 2025 6:30 am
SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts - May 1st, 2025 10:46 am
SurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to Say - Apr 30th, 2025 8:00 am
SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates - Apr 30th, 2025 6:15 am
SurModics: Fiscal Q2 Earnings Snapshot - Apr 30th, 2025 5:14 am
Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance - Apr 30th, 2025 5:00 am
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30 - Apr 28th, 2025 4:00 pm
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon - Apr 22nd, 2025 5:00 am
Illinois, Minnesota join FTC challenge against $627M Surmodics buyout - Apr 18th, 2025 5:00 am
SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System - Apr 4th, 2025 10:36 am
Surmodics launches Pounce XL thrombectomy system - Apr 3rd, 2025 10:41 am
Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries - Apr 3rd, 2025 5:00 am
Here's Why You Should Retain Surmodics Stock in Your Portfolio Now - Mar 18th, 2025 4:47 am
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics - Mar 10th, 2025 7:30 am
SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge - Mar 7th, 2025 1:00 pm
FTC challenges $627M private equity takeover of Surmodics - Mar 7th, 2025 3:00 am
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR - Mar 6th, 2025 7:00 pm
US FTC sues to block private equity purchase of medical company - Mar 6th, 2025 2:22 pm